Mednet Logo
CommunityMedical Oncology

Do you offer adjuvant therapy for localized medullary carcinoma of the ascending colon that is MSI-H?

Do you use the same high risk factors as adenocarcinoma when deciding on adjuvant treatment for early stage disease?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Indiana University Melvin and Bren Simon Cancer Center
Answered on

Medullary carcinoma of the colon is a rare type of colon cancer with unique clinical and molecular features. Despite its high-grade histology, its prognosis is generally better than adenocarcinoma. They tend to be locally advanced and rarely metastasize. They are usually MSI-H with a high number of ...

Join for free or sign in to see the full answer